Erwin Estigarribia
Geen lopende functies
Profiel
Erwin V.
Estigarribia held several positions in different companies, including Chief Executive Officer at Venn Biosciences Corp., Senior Director-Manufacturing Sciences at Geron Corp., Associate Director-Process Development at Novartis Vaccines & Diagnostics, Inc., Principal at CSL Ltd.
and Porocrit & Sims Sfe LLC, Vice President-Manufacturing & Quality Operations at Tecan Genomics, Inc., Vice President-Operations at CardioDx, Inc., and Vice President-Commercial Operations at Applied Proteomics, Inc. He obtained an undergraduate degree from Swinburne University of Technology.
Eerdere bekende functies van Erwin Estigarribia
| Bedrijven | Functie | Einde |
|---|---|---|
Venn Biosciences Corp.
 Venn Biosciences Corp. BiotechnologyHealth Technology Venn Biosciences Corp. engages in developing an artificial intelligence-driven mass spectrometry discovery and validation platform. Its products include VENN Vista, a glycoproteomic analysis; OpenPIP software, a neural network for automated mass spectrometry peak integration; and cancer liquid biopsy. The company was founded by Lieza Denan, Aldo Carrascoso, Carlito B. Lebrilla, and Carolyn R. Bertozzi in June 2017 and is headquartered in South San Francisco, CA. | Algemeen Directeur | 27-09-2023 |
| CARDIODX INC | Operationeel Directeur | - |
Applied Proteomics, Inc.
 Applied Proteomics, Inc. Medical/Nursing ServicesHealth Services Applied Proteomics, Inc. develops protein biomarkers for the healthcare and drug development sectors. It specializes in blood-based multiplex protein tests to help physicians, direct patients towards current standard-of-care patient management. The company was founded by David B. Agus and W. Daniel Hillis in May 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
| CSL LIMITED | Corporate Officer/Principal | - |
| Porocrit & Sims Sfe LLC | Corporate Officer/Principal | - |
Opleiding van Erwin Estigarribia
| Swinburne University of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| GERON CORPORATION | Health Technology |
| CSL LIMITED | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Tecan Genomics, Inc.
 Tecan Genomics, Inc. Electronic Equipment/InstrumentsElectronic Technology Tecan Genomics, Inc. provides genomics sample preparation solutions. It offers solutions which make biological samples accessible for genomic analysis. The firm has commercialized numerous proprietary DNA and RNA sample preparation products for use in research and diagnostic applications. The company was founded by Jan D'Alvise, James W. Larrick and Nurith Kurn in 2000 and is headquartered in San Carlos, CA. | Electronic Technology |
CardioDx, Inc.
 CardioDx, Inc. Medical/Nursing ServicesHealth Services CardioDx, Inc. operates as a cardiovascular genomic diagnostics firm. It develops proprietary tests that improve treatment decisions and patient outcomes on coronary artery disease, cardiac arrhythmia, and heart failure. The company was founded by David L. Levison and Christopher R. Burrow in 2004 and is headquartered in Redwood, CA. | Health Services |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |
| Porocrit & Sims Sfe LLC | |
Applied Proteomics, Inc.
Applied Proteomics, Inc. Medical/Nursing ServicesHealth Services Applied Proteomics, Inc. develops protein biomarkers for the healthcare and drug development sectors. It specializes in blood-based multiplex protein tests to help physicians, direct patients towards current standard-of-care patient management. The company was founded by David B. Agus and W. Daniel Hillis in May 2007 and is headquartered in San Diego, CA. | Health Services |
Venn Biosciences Corp.
Venn Biosciences Corp. BiotechnologyHealth Technology Venn Biosciences Corp. engages in developing an artificial intelligence-driven mass spectrometry discovery and validation platform. Its products include VENN Vista, a glycoproteomic analysis; OpenPIP software, a neural network for automated mass spectrometry peak integration; and cancer liquid biopsy. The company was founded by Lieza Denan, Aldo Carrascoso, Carlito B. Lebrilla, and Carolyn R. Bertozzi in June 2017 and is headquartered in South San Francisco, CA. | Health Technology |
